These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China. Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294 [TBL] [Abstract][Full Text] [Related]
6. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013. Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179 [TBL] [Abstract][Full Text] [Related]
7. The Evolution and Transmission Dynamics of Multidrug-Resistant Tuberculosis in an Isolated High-Plateau Population of Tibet, China. Jiang Q; Liu HC; Liu QY; Phelan JE; Tao FX; Zhao XQ; Wang J; Glynn JR; Takiff HE; Clark TG; Wan KL; Gao Q Microbiol Spectr; 2023 Mar; 11(2):e0399122. PubMed ID: 36912683 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. Desissa F; Workineh T; Beyene T BMC Public Health; 2018 Apr; 18(1):422. PubMed ID: 29606112 [TBL] [Abstract][Full Text] [Related]
9. Genotyping and molecular detection of multidrug-resistant Zewdie O; Mihret A; Abebe T; Kebede A; Desta K; Worku A; Ameni G New Microbes New Infect; 2018 Jan; 21():36-41. PubMed ID: 29675262 [TBL] [Abstract][Full Text] [Related]
11. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Lange C; Abubakar I; Alffenaar JW; Bothamley G; Caminero JA; Carvalho AC; Chang KC; Codecasa L; Correia A; Crudu V; Davies P; Dedicoat M; Drobniewski F; Duarte R; Ehlers C; Erkens C; Goletti D; Günther G; Ibraim E; Kampmann B; Kuksa L; de Lange W; van Leth F; van Lunzen J; Matteelli A; Menzies D; Monedero I; Richter E; Rüsch-Gerdes S; Sandgren A; Scardigli A; Skrahina A; Tortoli E; Volchenkov G; Wagner D; van der Werf MJ; Williams B; Yew WW; Zellweger JP; Cirillo DM; Eur Respir J; 2014 Jul; 44(1):23-63. PubMed ID: 24659544 [TBL] [Abstract][Full Text] [Related]
12. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant. Tesfay K; Tesfay S; Nigus E; Gebreyesus A; Gebreegziabiher D; Adane K Int J Mycobacteriol; 2016 Sep; 5(3):324-327. PubMed ID: 27847018 [TBL] [Abstract][Full Text] [Related]
13. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region. Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319 [TBL] [Abstract][Full Text] [Related]
14. Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018. McDowell A; Haas M; Seaworth B; Wilson JW; Patrawalla A; Haley C; Lauzardo M; de Bruyn M; Goswami ND J Clin Tuberc Other Mycobact Dis; 2021 Feb; 22():100201. PubMed ID: 33336084 [TBL] [Abstract][Full Text] [Related]
15. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study. Admassu F; Abera E; Gizachew A; Sedoro T; Gari T BMJ Open; 2023 Jan; 13(1):e061836. PubMed ID: 36639214 [TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. Elmi OS; Hasan H; Abdullah S; Mat Jeab MZ; Bin Alwi Z; Naing NN J Infect Dev Ctries; 2015 Oct; 9(10):1076-85. PubMed ID: 26517482 [TBL] [Abstract][Full Text] [Related]
17. Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam. Hoang TT; Nguyen NV; Dinh SN; Nguyen HB; Cobelens F; Thwaites G; Nguyen HT; Nguyen AT; Wright P; Wertheim HF BMC Public Health; 2015 Sep; 15():980. PubMed ID: 26415893 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study. Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148 [TBL] [Abstract][Full Text] [Related]
19. Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015. Ködmön C; van den Boom M; Zucs P; van der Werf MJ Euro Surveill; 2017 Nov; 22(47):. PubMed ID: 29183553 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Ahmad S; Mokaddas E Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]